EyePoint (EYPT) Operating Income Growth (3y) (2013 - 2026)
EyePoint (EYPT) Operating Income Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,899.61 Bn | 65,899.33 Bn | - | 16.96% |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 471.67 Bn | 466.88 Bn | 1.35 Bn | 38.78% |
| 5 | Vertex Pharmaceuticals | 122.32 Bn | 115.07 Bn | 2.59 Bn | 13.47% |
| 6 | Regeneron Pharmaceuticals | 70.04 Bn | 61.29 Bn | 3.31 Bn | -12.10% |
| 7 | Belite Bio | 62.06 Bn | 62.06 Bn | - | - |
| 8 | Argenx Se | 55.93 Bn | 50.74 Bn | 1.41 Bn | 69.02% |
| 9 | Alnylam Pharmaceuticals | 37.55 Bn | 34.54 Bn | 959.66 Mn | 55.96% |
| 10 | EyePoint | 1.07 Mn | -221.48 Mn | 168,000.00 | -59.36% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -59.36% |
| Dec 31, 2025 | -17.17% |
| Sep 30, 2025 | -49.95% |
| Jun 30, 2025 | -47.95% |
| Mar 31, 2025 | -38.75% |
| Dec 31, 2024 | -35.84% |
| Sep 30, 2024 | -28.84% |
| Jun 30, 2024 | -46.54% |
| Mar 31, 2024 | -44.98% |
| Dec 31, 2023 | -8.69% |
| Sep 30, 2023 | -94.49% |
| Jun 30, 2023 | -26.85% |
| Mar 31, 2023 | -23.50% |
| Dec 31, 2022 | -69.47% |
| Sep 30, 2022 | -9.38% |
| Jun 30, 2022 | -23.65% |
| Mar 31, 2022 | -7.66% |
| Dec 31, 2021 | 9.76% |
| Sep 30, 2021 | 18.24% |
| Jun 30, 2021 | 8.77% |